Framework agreement for the provision of high tech homecare medicines services (including

lot A compounded desferrioxamine) to members of the Yorkshire and Humber NHS

Pharmaceutical Purchasing Consortium, and other organisations with prior approval only.

This framework will be subject to the release of mini competitions for specific high homecare

services.

Services are to be provided in line with the Royal Pharmaceutical Society Professional

Standards for Homecare.

This framework agreement will be accessible to all partly or wholly publically funded bodies

in the United Kingdom, including Northern Ireland, Scotland, Wales and England. This will

include, but is not limited to: Acute; (including their third party providers); Ambulance;

Mental Health; Clinical Commissioning Groups; Health and Care Trusts; Area Teams; Local

Authorities and Special Health Authorities; HSC in Northern Ireland; NHS Scotland and NHS

Wales, including any successor or emerging organisations, which will include but is not

limited to the emerging landscape of combined health and social care commissioners and

providers.

Framework agreement for the provision of high tech homecare medicines services to members of the Yorkshire and Humber NHS Pharmaceutical Purchasing Consortium, and other organisations with prior approval only.

This framework will be subject to the release of mini competitions for specific high homecare

services.

Framework agreement for the provision of Compounded Desferrioxamine homecare medicines services to members of the Yorkshire and Humber NHS Pharmaceutical Purchasing Consortium, and other organisations with prior approval only.